The Scotsman

Cannabis-oil medicine wins ap­proval

- By NEIL POORAN Health · Pharmaceutical Industry · Cancer · Medications · Medicine · Pharmacology · Society · Therapy · Neurology · Medical Treatments · Industries · Health Conditions · England

Ac anna bid­iol(CBD) medicine has been ap­proved for use on the NHS to treat two rare forms of epilepsy.

The Scot­tish Medicines Con­sor­tium (SMC) has ap­proved E pi dyol ex for Lenn ox-Gas­tau t syn­drome and Dr a vet syn­drome – types of epilepsy that can have a se­vere im­pact on chil­dren.

The de­ci­sion means pa­tients aged two and over can ac­cess the medicine via the NHS if their doc­tor rec­om­mends it. Physi­cians in England have been able to pre­scribe the cannabis-based so­lu­tion since Jan­uary.

Health sec­re­tary Jeane Free­man said: “We wel­come the de­ci­sion to ap­prove Epidy­olex for the treat­ment of Len­noxGas taut syn­drome–a rare type of epilepsy that presents in early child­hood – and the ad­di­tional sup­port this will give fam­i­lies liv­ing with chil­dren suf­fer­ing from this con­di­tion.

“To­gether with the ap­proval of Epidy­olex in com­bi­na­tion with c lob az am, which was also ac­cepted for the treat­ment of Dr a vet syn­drome, th­ese medicines will im­prove the qual­ity of life for pa­tients and their fam­i­lies.”

The char­ity Epilepsy Con­nec­tions said it helped to give in­put to the SMC as part of its pa­tient and clin­i­cian en­gage­ment (PACE) process for the CBD ther­apy.

The medicines are part of 14 ap­proved by SMC, in­clud­ing a drug for breast cancer pa­tients called Per­jeta.

Newspapers in English

Newspapers from UK